NORDIC BIOSCIENCE CLINICAL STUDIES A/S: Financial statements 2013
CVR: 21144347
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
NORDIC BIOSCIENCE CLINICAL STUDIES A/S (CVR 21144347) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 52,902 and a net result of DKK -2,089,315. Equity in the 2013 report amounted to DKK -648,075.
- Gross Profit
- DKK 52,902
- Profit/Loss
- DKK -2,089,315
- Equity
- DKK -648,075
- Total Assets
- DKK 1,498,380
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 53 t. | -2.1 mio. | -648 t. | - |
| 2012 | - | - | - | 1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
NORDIC BIOSCIENCE CLINICAL STUDIES A/S has published its annual report for 2012.
As of February 6, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of February 6, 2013, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has stepped down as auditor of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of January 2, 2013, Hervé Girsault has joined the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
As of January 2, 2013, Thomas Nielsen has left the board of directors of NORDIC BIOSCIENCE CLINICAL STUDIES A/S.
About NORDIC BIOSCIENCE CLINICAL STUDIES A/S
NORDIC BIOSCIENCE CLINICAL STUDIES A/S was a Danish company of the type Aktieselskab based in Herlev, founded in 1998. The company has been dissolved on 26 November 2014. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named NORDIC BIOSCIENCE A/S and OSTEOPRO A/S. The company has 2 employees (2009). In 2013, the company reported a gross profit of DKK 52,902 and a net result of DKK -2,089,315. Equity in the 2013 report amounted to DKK -648,075.